CAJ | 학술논문

目的：通过临床试验对比，探讨参一胶囊联合FuP化疗方案对胃癌疗效的促进作用。方法选取我院2010年1月～2012年3月间确诊并收治的胃癌患者100例，随机分为对照组和实验组。对照组使用化疗配合安慰剂治疗，实验组，使用参一胶囊替换安慰剂治疗。观察两组患者的疗效，不良反应等情况，并作统计学分析。结果实验组总有效率和生活质量评分方面优于对照组，且差异具有统计学意义（P＜0.05）。实验组白细胞计数、血红蛋白、血小板减少情况明显低于对照组，差异具有统计学意义，其他不良反应指标无统计学差异。结论在化疗过程联合使用参一胶囊治疗胃癌，可明显提高疗效，有助于延长患者的生存期，值得临床推广。
목적：통과림상시험대비，탐토삼일효낭연합FuP화료방안대위암료효적촉진작용。방법선취아원2010년1월～2012년3월간학진병수치적위암환자100례，수궤분위대조조화실험조。대조조사용화료배합안위제치료，실험조，사용삼일효낭체환안위제치료。관찰량조환자적료효，불량반응등정황，병작통계학분석。결과실험조총유효솔화생활질량평분방면우우대조조，차차이구유통계학의의（P＜0.05）。실험조백세포계수、혈홍단백、혈소판감소정황명현저우대조조，차이구유통계학의의，기타불량반응지표무통계학차이。결론재화료과정연합사용삼일효낭치료위암，가명현제고료효，유조우연장환자적생존기，치득림상추엄。
Objective To compare the clinical trials to explore the promotion of the role of SHENYIJIAONANG combined FuP a chemotherapy treatment for stomach cancer effect.Methods Gastric cancer patients in our hospital in January 2010 between March 2012 diagnosed and treated 100 cases,randomly divided into control and experimental groups.The control group using chemotherapy with placebo.Experimental group, replacing placebo. the use of SHENYIJIAONANG..Therapeutic effects were observed, and adverse reactions, etc., and for statistical analysis. Results The experimental group, the total efifciency and quality of life scores better than the control group,And the difference was statistically signiifcant (P<0.05).The experimental group leukocyte count, hemoglobin, thrombocytopenia cases significantly lower than the control group, the difference was statistically significant, other indicators of adverse reactions was no signiifcant difference.Conclusion In the course of chemotherapy combined use of SHENYIJIAONANG treatment of gastric cancer, can signiifcantly improve the therapeutic effect, helps to prolong survival of patients, worthy of promotion.